MBX Biosciences, Inc. (MBX): 8 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Mar 16, 2026 | Hawryluk P. Kent Director, Officer | 18,500 | $28.41 | $525.6K | no history |
| Oct 21, 2025 | Hawryluk P. Kent Director, Officer | 20,000 | $13.64 | $272.8K | no history |
| Oct 20, 2025 | Hoerter Steven L. Director | 20,000 | $13.25 | $265.0K | no history |
| Sep 30, 2025 | Fhmls X, L.P. TenPercentOwner | 666,666 | $18.00 | $12.0M | no history |
| Apr 10, 2025 | Pescovitz Ora H. Director | 7,693 | $5.89 | $45.3K | no history |
| Feb 19, 2025 | OrbiMed Genesis GP LLC Director, TenPercentOwner | 190,672 | $10.60 | $2.0M | no history |
| Feb 19, 2025 | Gordon Carl L Director, TenPercentOwner | 190,672 | $10.60 | $2.0M | no history |
| Feb 5, 2025 | Hawryluk P. Kent Director, Officer | 50,000 | $10.69 | $534.5K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.